Unknown

Dataset Information

0

WWOX Phosphorylation, Signaling, and Role in Neurodegeneration.


ABSTRACT: Homozygous null mutation of tumor suppressor WWOX/Wwox gene leads to severe neural diseases, metabolic disorders and early death in the newborns of humans, mice and rats. WWOX is frequently downregulated in the hippocampi of patients with Alzheimer's disease (AD). In vitro analysis revealed that knockdown of WWOX protein in neuroblastoma cells results in aggregation of TRAPPC6A?, TIAF1, amyloid ?, and Tau in a sequential manner. Indeed, TRAPPC6A? and TIAF1, but not tau and amyloid ?, aggregates are present in the brains of healthy mid-aged individuals. It is reasonable to assume that very slow activation of a protein aggregation cascade starts sequentially with TRAPPC6A? and TIAF1 aggregation at mid-ages, then caspase activation and APP de-phosphorylation and degradation, and final accumulation of amyloid ? and Tau aggregates in the brains at greater than 70 years old. WWOX binds Tau-hyperphosphorylating enzymes (e.g., GSK-3?) and blocks their functions, thereby supporting neuronal survival and differentiation. As a neuronal protective hormone, 17?-estradiol (E2) binds WWOX at an NSYK motif in the C-terminal SDR (short-chain alcohol dehydrogenase/reductase) domain. In this review, we discuss how WWOX and E2 block protein aggregation during neurodegeneration, and how a 31-amino-acid zinc finger-like Zfra peptide restores memory loss in mice.

SUBMITTER: Liu CC 

PROVIDER: S-EPMC6104168 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

WWOX Phosphorylation, Signaling, and Role in Neurodegeneration.

Liu Chan-Chuan CC   Ho Pei-Chuan PC   Lee I-Ting IT   Chen Yu-An YA   Chu Chun-Hsien CH   Teng Chih-Chuan CC   Wu Sheng-Nan SN   Sze Chun-I CI   Chiang Ming-Fu MF   Chang Nan-Shan NS  

Frontiers in neuroscience 20180815


Homozygous null mutation of tumor suppressor <i>WWOX/Wwox</i> gene leads to severe neural diseases, metabolic disorders and early death in the newborns of humans, mice and rats. WWOX is frequently downregulated in the hippocampi of patients with Alzheimer's disease (AD). <i>In vitro</i> analysis revealed that knockdown of WWOX protein in neuroblastoma cells results in aggregation of TRAPPC6AΔ, TIAF1, amyloid β, and Tau in a sequential manner. Indeed, TRAPPC6AΔ and TIAF1, but not tau and amyloid  ...[more]

Similar Datasets

| S-EPMC10970703 | biostudies-literature
| S-EPMC5788152 | biostudies-literature
| S-EPMC5398941 | biostudies-literature
| S-EPMC4026737 | biostudies-literature
| S-EPMC3585961 | biostudies-literature
| S-EPMC3347543 | biostudies-literature
| S-EPMC2689218 | biostudies-literature
| S-EPMC6895976 | biostudies-literature
| S-EPMC4166600 | biostudies-literature
| S-EPMC7016793 | biostudies-literature